| Literature DB >> 16209921 |
Kimitoshi Kohno1, Takeshi Uchiumi, Ichiro Niina, Tetsuro Wakasugi, Tomonori Igarashi, Yasutomo Momii, Takeshi Yoshida, Ken-Ichi Matsuo, Naoya Miyamoto, Hiroto Izumi.
Abstract
Intrinsic or acquired resistance to anticancer agents is a major obstacle to the success of chemotherapy. Anticancer agents are known to modulate signal transduction pathways and alter expression of genes that play an important role in drug resistance. Emerging evidence suggests that the complexity of genomic response against anticancer agents arise from elaborate gene expression by multiple transcription factors. Here, we briefly describe the development of solid tumours and the appearance of drug-resistant cells. We also review what is known of the transcription factors that are involved in resistance to drugs, particularly cisplatin.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16209921 DOI: 10.1016/j.ejca.2005.08.007
Source DB: PubMed Journal: Eur J Cancer ISSN: 0959-8049 Impact factor: 9.162